Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.56 USD 6.63% Market Closed
Market Cap: 554.4m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Total Assets
$319.8m
CAGR 3-Years
21%
CAGR 5-Years
156%
CAGR 10-Years
95%
Bausch Health Companies Inc
TSX:BHC
Total Assets
$26.5B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
0%
Sundial Growers Inc
NASDAQ:SNDL
Total Assets
CA$1.5B
CAGR 3-Years
71%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Total Assets
$1.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Total Assets
CA$962.3m
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Total Assets
$3.2B
CAGR 3-Years
11%
CAGR 5-Years
698%
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
554.4m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
3.7 USD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Total Assets?
Total Assets
319.8m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Total Assets amounts to 319.8m USD.

What is Mind Medicine (MindMed) Inc's Total Assets growth rate?
Total Assets CAGR 10Y
95%

Over the last year, the Total Assets growth was 126%. The average annual Total Assets growth rates for Mind Medicine (MindMed) Inc have been 21% over the past three years , 156% over the past five years , and 95% over the past ten years .

Back to Top